'In the ideal position': Neuren Pharmaceuticals books profit and looks to second treatment after positive results

Neuren Pharmaceuticals chief executive Jon Pilcher. (Image: Neuren Pharmaceuticals)

Tue, 27 Aug 2024

Listed pharmaceutical firm Neuren says it is expecting to earn up to A$150 million in royalties in the US for its groundbreaking treatment for Rett Syndrome. Neuren, listed on the Australian Securities Exchange, posted its half-year result for the six months to June 30 on Tuesday. The New Zealand registered company posted an A$8m (NZ$8.7m) after-tax profit, which was a fall from the prior comparable half of $39.8m. Neuren said on Tuesday it earned royalty income of A$24.3m, an increase from A$3.5m in the first half of the 2023 fi...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Already a Subscriber ? Sign in here.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}